Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Fisher Syndrome

  • Chapter
  • First Online:
Neuroimmunological Diseases

Abstract

Fisher syndrome (FS) is a regional variant of Guillain–Barré syndrome (GBS) characterized by acute ophthalmoplegia, ataxia, and areflexia. It has a male predominant sex difference with a M:F ratio of ~2:1, and 70 % of FS patients have episodes of antecedent respiratory infection. The annual incidence varies geographically and is higher in Far East countries. As a variant of GBS, immunotherapies are sometimes applied to FS, but the efficacies and benefits of these treatments have not been established. The most important diagnostic marker is serum IgG anti-ganglioside GQ1b antibody, which is present in 80–95 % of FS patients. Using this antibody as a nosological marker has revealed a presumed relationship between FS and other conditions, including Bickerstaff brainstem encephalitis. Anti-GQ1b antibody may be actively involved in the pathogenic process of FS. The localization of the GQ1b epitope in the human ocular motor nerves, muscle spindle, and dorsal root ganglia could reasonably explain all of the core clinical features and physiological observations of this disease. GQ1b-mimic oligosaccharide structures have been identified in bacterial lipooligosaccharides, and immunization with these lipooligosaccharides produces anti-GQ1b antibodies. Siglec-7, a sialic acid-binding Ig-like lectin expressed on monocytes and macrophages, strongly binds to GQ1b and may be involved in antigen-presentation and the induction of anti-GQ1b antibody.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255:57–65.

    Article  CAS  PubMed  Google Scholar 

  2. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677–9.

    Article  CAS  PubMed  Google Scholar 

  3. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–7.

    Article  CAS  PubMed  Google Scholar 

  4. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 1996;39:668–72.

    Article  CAS  PubMed  Google Scholar 

  5. Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999;22:1071–4.

    Article  CAS  PubMed  Google Scholar 

  6. Mori M, Kuwabara S, Koga M, Asahina M, Ogawara K, Hattori T, Yuki N. IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiatry. 1999;67:668–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J Neurol Sci. 1993;118:83–7.

    Article  CAS  PubMed  Google Scholar 

  8. Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci. 2009;50:3226–32. doi:10.1167/iovs.08-3333.

    Article  PubMed  Google Scholar 

  9. Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110:100–6.

    Article  PubMed  Google Scholar 

  10. Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand. 1994;89:287–92.

    Article  CAS  PubMed  Google Scholar 

  11. Lolekha P, Phanthumchinda K. Miller-Fisher syndrome at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2009;92:471–7.

    PubMed  Google Scholar 

  12. Zhang G, Li Q, Zhang R, Wei X, Wang J, Qin X. Subtypes and prognosis of Guillain-Barré syndrome in southwest China. PLoS One. 2015;10:e0133520. doi:10.1371/journal.pone.0133520. eCollection 2015.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int. 2010;52:13–9. doi:10.1111/j.1442-200X.2009.02951.x.

    Article  PubMed  Google Scholar 

  14. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997;63:494–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yuan CL, Wang YJ, Tsai CP. Miller fisher syndrome: a hospital-based retrospective study. Eur Neurol. 2000;44:79–85.

    Article  CAS  PubMed  Google Scholar 

  16. Tsuboi H, Sugeno N, Tateyama M, Nakashima I, Hasegawa T, Kuroda H, Kaneko K, Kobayashi M, Ishigaki A, Fujimori J, Aoki M. Retrospective analysis of Guillain-Barré syndrome and Fisher syndrome after the great east Japan earthquake. Brain Behav. 2014;4:595–7. doi:10.1002/brb3.234.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–6.

    Article  CAS  PubMed  Google Scholar 

  18. Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, Sonoo M, Takada K, Japanese GBS Study Group. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry. 2015;86:110–4. doi:10.1136/jnnp-2013-306509.Epub2013Nov22.

    Article  PubMed  Google Scholar 

  19. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33. doi:10.1159/000324710.

    Article  PubMed  Google Scholar 

  20. Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992;12:57–63.

    CAS  PubMed  Google Scholar 

  21. Mori M, Kuwabara S, Yuki N. Fisher syndrome: clinical features, immunopathogenesis and management. Expert Rev Neurother. 2012;12:39–51. doi:10.1586/ern.11.182.

    Article  CAS  PubMed  Google Scholar 

  22. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005;64:1605–11.

    Article  CAS  PubMed  Google Scholar 

  23. Arányi Z, Kovács T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol. 2012;19:15–20. doi:10.1111/j.1468-1331.2011.03445.x. e1-3.

    Article  PubMed  Google Scholar 

  24. Susuki K, Yuki N, Muramatsu M, Hirata K. Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol. 2000;247:652–3.

    Article  CAS  PubMed  Google Scholar 

  25. Smith J, Clarke L, Severn P, Boyce R. Unilateral external ophthalmoplegia in Miller Fisher syndrome: case report. BMC Ophthalmol. 2007;7:7.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Toshniwal P. Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol. 1987;234:353–8.

    Article  CAS  PubMed  Google Scholar 

  27. Colding-Jørgensen E, Vissing J. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand. 2001;103:259–60.

    Article  PubMed  Google Scholar 

  28. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome, Contemporary neurology series 34. Philadelphia: F.A.Davis; 1991.

    Google Scholar 

  29. Koga M, Kusunoki S, Kaida K, Uehara R, Nakamura Y, Kohriyama T, Kanda T. Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry. 2012;83:1210–5. doi:10.1136/jnnp-2012-303060.

    Article  PubMed  Google Scholar 

  30. Al-Din AN, Anderson M, Bickerstaff ER, Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982;105:481–95.

    Article  PubMed  Google Scholar 

  31. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, Yuki N. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255:674–82. doi:10.1007/s00415-008-0775-0.

    Article  CAS  PubMed  Google Scholar 

  32. Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, Kamakura K, Kusunoki S. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes. J Neurol Neurosurg Psychiatry. 2008;79:1148–52. doi:10.1136/jnnp.2007.142950.

    Article  CAS  PubMed  Google Scholar 

  33. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004;148:200–5.

    Article  CAS  PubMed  Google Scholar 

  34. Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain. 1988;111:95–114.

    Article  PubMed  Google Scholar 

  35. Sauron B, Bouche P, Cathala HP, Chain F, Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology. 1984;34:953–6.

    Article  CAS  PubMed  Google Scholar 

  36. Dachy B, Deltenre P, Deconinck N, Dan B. The H reflex as a diagnostic tool for Miller Fisher syndrome in pediatric patients. J Clin Neurosci. 2010;17:410–1. doi:10.1016/j.jocn.2009.06.014.

    Article  CAS  PubMed  Google Scholar 

  37. Sekiguchi Y, Misawa S, Shibuya K, Mitsuma S, Hirano S, Ohmori S, Koga S, Iwai Y, Beppu M, Kuwabara S. Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents. Clin Neurophysiol. 2013;124:1465–9. doi:10.1016/j.clinph.2013.01.020.

    Article  PubMed  Google Scholar 

  38. Nagaoka U, Kato T, Kurita K, Arawaka S, Hosoya T, Yuki N, Shikama Y, Yamaguchi K, Sasaki H. Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology. 1996;47:1601–2.

    Article  CAS  PubMed  Google Scholar 

  39. Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol. 1998;126:322–4.

    Article  CAS  PubMed  Google Scholar 

  40. Shibata A, Hosoya T, Kato T, Yuki N, Nagaoka U, Adachi M, Haku T, Yamaguchi K. Abducens nerve enhancement in acute ophthalmoparesis. Radiat Med. 1998;16:375–7.

    CAS  PubMed  Google Scholar 

  41. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70:50–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612. doi:10.1016/j.vaccine.2010.06.003.

    Article  PubMed  Google Scholar 

  43. Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes – new diagnostic classification. Nat Rev Neurol. 2014;10:537–44. doi:10.1038/nrneurol.2014.138.

    Article  PubMed  Google Scholar 

  44. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007;68:1144–6.

    Article  CAS  PubMed  Google Scholar 

  45. Overell JR, Hsieh ST, Odaka M, Yuki N, Willison HJ. Treatment for Fisher syndrome, Bickerstaff’s brainstem encephalitis and related disorders. Cochrane Database Syst Rev. 2007;24:CD004761.

    Google Scholar 

  46. Kaida K, Kusunoki S, Kanzaki M, Kamakura K, Motoyoshi K, Kanazawa I. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology. 2004;62:821–4.

    Article  CAS  PubMed  Google Scholar 

  47. Chida K, Nomura H, Konno H, Takase S, Itoyama Y. Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci. 1999;165:139–43.

    Article  CAS  PubMed  Google Scholar 

  48. Neshige S, Yoshimoto T, Takeshima S, Himeno T, Shimoe Y, Takamatsu K, Kuriyama M. Clinical analyses of recurrence in Guillain-Barré syndrome and Fisher syndrome. Rinsho Shinkeigaku. 2014;54:577–80. Japanese.

    Article  PubMed  Google Scholar 

  49. Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9. doi:10.1136/jnnp.2008.156463.

    Article  CAS  PubMed  Google Scholar 

  50. Grand’Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain. 1992;115:1093–106.

    Article  PubMed  Google Scholar 

  51. Heckmann JG, Dütsch M. Recurrent Miller Fisher syndrome: clinical and laboratory features. Eur J Neurol. 2012;19:944–54. doi:10.1111/j.1468-1331.2011.03584.x.

    Article  CAS  PubMed  Google Scholar 

  52. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol. 1994;50:159–65.

    Article  CAS  PubMed  Google Scholar 

  53. Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol. 2012;259:1366–74. doi:10.1007/s00415-011-6360-y.

    Article  CAS  PubMed  Google Scholar 

  54. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997;745:32–6.

    Article  CAS  PubMed  Google Scholar 

  55. Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, Yuki N. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol. 1999;45:533–6.

    Article  CAS  PubMed  Google Scholar 

  56. Harper AA, Lawson SN. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. J Physiol. 1985;359:31–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Lee KH, Chung K, Chung JM, Coggeshall RE. Correlation of cell body size, axon size, and signal conduction velocity for individually labelled dorsal root ganglion cells in the cat. J Comp Neurol. 1986;243:335–46.

    Article  CAS  PubMed  Google Scholar 

  58. Houliston RS, Koga M, Li J, Jarrell HC, Richards JC, Vitiazeva V, Schweda EK, Yuki N, Gilbert M. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry. 2007;46:8164–71.

    Article  CAS  PubMed  Google Scholar 

  59. Goodyear CS, O’Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999;104:697–708. Erratum in: J Clin Invest. 1999;104:1771.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meché FG, van Doorn PA. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Infect Immun. 2001;69:2462–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem. 2002;277:327–37.

    Article  CAS  PubMed  Google Scholar 

  62. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology. 2005;65:1376–81.

    Article  CAS  PubMed  Google Scholar 

  63. Chiba A, Kusunoki S, Kuwata S, Juji T, Shibata Y, Kanazawa I. HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome. J Neuroimmunol. 1995;61:85–8.

    Article  CAS  PubMed  Google Scholar 

  64. Rapoport E, Mikhalyov I, Zhang J, Crocker P, Bovin N. Ganglioside binding pattern of CD33-related siglecs. Bioorg Med Chem Lett. 2003;13:675–8.

    Article  CAS  PubMed  Google Scholar 

  65. Avril T, Wagner ER, Willison HJ, Crocker PR. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun. 2006;74:4133–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Attrill H, Imamura A, Sharma RS, Kiso M, Crocker PR, van Aalten DM. Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. J Biol Chem. 2006;281:32774–83.

    Article  CAS  PubMed  Google Scholar 

  67. Heikema AP, Jacobs BC, Horst-Kreft D, Huizinga R, Kuijf ML, Endtz HP, Samsom JN, van Wamel WJ. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome. Clin Microbiol Infect. 2013;19:E106–12. doi:10.1111/1469-0691.12073.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Faculty of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan

    Atsuro Chiba

Authors
  1. Atsuro Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsuro Chiba .

Editor information

Editors and Affiliations

  1. Kindai University School of Medicine, Department of Neurology, Osaka-Sayama, Osaka, Japan

    Susumu Kusunoki

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Chiba, A. (2016). Fisher Syndrome. In: Kusunoki, S. (eds) Neuroimmunological Diseases. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55594-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55594-0_11

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55593-3

  • Online ISBN: 978-4-431-55594-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation